Rivastigmine
The active substance of Rivaldo is rivastigmine. Rivastigmine belongs to a group of substances called cholinesterase inhibitors. In patients with Alzheimer's disease or Parkinson's disease dementia, certain brain cells die, which leads to a decrease in the concentration of the neurotransmitter acetylcholine (a substance that enables nerve cells to communicate with each other). The action of rivastigmine is to block the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase. By blocking the action of these enzymes, Rivaldo allows the concentration of acetylcholine in the brain to increase, which helps to alleviate the symptoms of Alzheimer's disease and Parkinson's disease dementia. Rivaldo is used to treat adult patients with mild to moderate Alzheimer's disease. Rivaldo is used to treat dementia in adult patients with Parkinson's disease.
If this situation applies to you, you should tell your doctor and not take Rivaldo.
Before starting treatment with Rivaldo, you should discuss it with your doctor or pharmacist:
If you have stopped taking Rivaldo for a few days, you should not take the next dose until you have talked to your doctor.
Rivaldo should not be used in children and adolescents for the treatment of Alzheimer's disease.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take. Rivaldo should not be taken with other medicines that have a similar effect. Rivaldo may affect the action of anticholinergic medicines (medicines used to relieve stomach cramps, treat Parkinson's disease, or prevent motion sickness). Rivaldo should not be taken with metoclopramide (a medicine used to relieve or prevent nausea and vomiting). Taking these two medicines together may cause disorders such as stiffness of the limbs and hand tremors. If you need to have surgery, you should tell your doctor that you are taking Rivaldo before receiving general anesthesia, as Rivaldo may increase the effect of some muscle relaxants used for general anesthesia. You should be careful when taking Rivaldo with beta-adrenergic blockers (such as atenolol, used to treat high blood pressure, angina, and other heart diseases). Taking these two medicines together may cause disorders such as slow heart rate (bradycardia) leading to fainting or loss of consciousness.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, you should consult your doctor or pharmacist before taking this medicine. If you are pregnant, your doctor will assess the benefits of taking Rivaldo against the possible effects of the medicine on the unborn child. Rivaldo should not be taken during pregnancy unless it is absolutely necessary. You should not breastfeed while taking Rivaldo.
Your doctor will inform you whether your condition allows you to drive or use machines safely. Rivaldo may cause dizziness and drowsiness, mainly at the beginning of treatment or when increasing the dose. If you feel dizzy or drowsy, you should not drive, operate machinery, or perform other tasks that require concentration.
This medicine should always be taken exactly as your doctor has instructed. If you are unsure, ask your doctor or pharmacist.
Your doctor will inform you what dose of Rivaldo to take.
Your doctor will regularly check if the medicine is working for you. During treatment with this medicine, your doctor will also monitor your weight. If you have stopped taking Rivaldo for more than three days, you should not take the next dose until you have talked to your doctor.
In case of unintentional ingestion of a higher dose of Rivaldo than recommended, you should inform your doctor, as medical attention may be necessary. In some people who have accidentally taken too much Rivaldo, nausea (nausea), vomiting, diarrhea, high blood pressure, and hallucinations have been observed. Slow heart rate and fainting may also occur.
If you have missed a dose of Rivaldo, you should wait and take the next dose at the usual scheduled time. You should not take a double dose to make up for the missed dose. If you have any further questions about taking this medicine, you should ask your doctor or pharmacist.
Like all medicines, Rivaldo can cause side effects, although not everybody gets them. Side effects usually occur during the initial treatment period or when increasing the dose. Side effects will gradually resolve as your body gets used to the treatment.
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
In these patients, some side effects occur more frequently. They may also experience additional symptoms:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Frequency not known(cannot be estimated from the available data)
If you experience any side effects, including those not listed in this leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Medical Devices, and Biocides, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of sight and reach of children. Do not use this medicine after the expiry date stated on the blister and carton. The expiry date refers to the last day of that month. There are no special precautions for storage. Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Capsule content: hypromellose, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate.
Coating: gelatin, sodium lauryl sulfate, titanium dioxide (E 171), yellow iron oxide (E 172).
Red ink: shellac; red iron oxide (E 172); soy lecithin; Antifoam DC; titanium dioxide (E 171); Allura Red, aluminum lake (E 129), propylene glycol.
Capsule content: hypromellose, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate.
Coating: gelatin, sodium lauryl sulfate, yellow iron oxide (E 172), red iron oxide (E 172), titanium dioxide (E 171).
Red ink: shellac; red iron oxide (E 172); soy lecithin; Antifoam DC; titanium dioxide (E 171); Allura Red, aluminum lake (E 129), propylene glycol.
Capsule content: hypromellose, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate.
Coating: gelatin, sodium lauryl sulfate, yellow iron oxide (E 172), red iron oxide (E 172), titanium dioxide (E 171).
White ink: shellac, titanium dioxide (E 171).
Capsule content: hypromellose, colloidal anhydrous silica, microcrystalline cellulose, magnesium stearate.
Coating: gelatin, sodium lauryl sulfate, yellow iron oxide (E 172), red iron oxide (E 172), titanium dioxide (E 171).
Red ink: shellac; red iron oxide (E 172); soy lecithin; Antifoam DC; titanium dioxide (E 171); Allura Red, aluminum lake (E 129), propylene glycol.
Rivaldo 1.5 mg: yellow capsule with red print "R 1.5" on the body, containing white or off-white powder.
Rivaldo 3.0 mg: orange capsule with red print "R 3.0" on the body, containing white or off-white powder.
Rivaldo 4.5 mg: red capsule with white print "R 4.5" on the body, containing white or off-white powder.
Rivaldo 6.0 mg: red-orange capsule with red print "R 6.0" on the body, containing white or off-white powder.
Rivaldo is packaged in blisters of 14 capsules.
Rivaldo 1.5 mg hard capsules
Single pack contains 28 capsules.
Rivaldo 3 mg, 4.5 mg, 6 mg hard capsules
Single pack contains 28 or 56 capsules.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Poland:
Rivaldo
Date of revision of the leaflet:03.2019
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.